Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Nabriva Therapeutics

    NASDAQ: NBRV · Real-Time Price · USD
    1.42
    0.01 (0.71%)
    At close: Jul 31, 2023, 10:00 PM

    Nabriva Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2022 FY 2021
    Period Ending Dec 31, 2022 Dec 31, 2021
    Revenue
    		 35.67M 27.22M
    Cost of Revenue
    		 28.58M 13.15M
    Gross Profit
    		 7.09M 14.07M
    Operating Income
    		 -55.49M -48.53M
    Interest Income
    		 n/a n/a
    Pretax Income
    		 -55.62M -48.96M
    Net Income
    		 -57.19M -49.45M
    Selling & General & Admin
    		 45.26M 51.65M
    Research & Development
    		 14.26M 12.63M
    Other Expenses
    		 -1.27M -1.68M
    Operating Expenses
    		 58.26M 62.6M
    Interest Expense
    		 698K n/a
    Selling & Marketing Expenses
    		 n/a n/a
    Cost & Expenses
    		 86.84M 75.74M
    Income Tax Expense
    		 1.57M 490K
    Shares Outstanding (Basic)
    		 2.68M 1.73M
    Shares Outstanding (Diluted)
    		 2.68M 1.73M
    EPS (Basic)
    		 -21.32 -28.52
    EPS (Diluted)
    		 -21.32 -28.52
    EBITDA
    		 -54.7M -48.53M
    EBIT
    		 -50.6M -49.86M
    Depreciation & Amortization
    		 -3.53M 637K

    Add to Watchlist